Glenmede Trust’s Cision Ltd. Ordinary Share CISN Stock Holding History

Glenmede Trust’s Portfolio CISN Stock Details CISN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-416	Closed	-$5	–	3254
2019 Q1	$5	Buy	+416	New	+$5.36K	﹤0.01%	2637

Other funds holding CISN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Glenmede Trust's CISN Position: Q2 2019 in Review

Glenmede Trust sold out of Cision Ltd. Ordinary Share (CISN) in Q2 2019, closing a stake of 416 shares — an estimated $5 sold.

Glenmede Trust first reported a position in CISN in Q1 2019 and held it in 1 quarter. The position peaked at $5 in Q1 2019. 116 funds tracked by Wall St. Rank hold CISN as of Q2 2019.

Glenmede Trust reported no remaining Cision Ltd. Ordinary Share position as of Q2 2019 after selling out during the quarter.
Glenmede Trust sold 416 Cision Ltd. Ordinary Share shares in Q2 2019, an estimated $5.
Glenmede Trust first reported a position in Cision Ltd. Ordinary Share in Q1 2019 and held it in 1 quarter.
Glenmede Trust's Cision Ltd. Ordinary Share position peaked at $5 in Q1 2019.
116 funds tracked by Wall St. Rank held Cision Ltd. Ordinary Share as of Q2 2019.

Based on Glenmede Trust's 13F filing for Q2 2019, filed 13 Aug 2019.